Institutional investors purchased a net $210.0 thousand shares of TXMD during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 56.28% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OLD MUTUAL INVESTMENT MANAGEMENT... Bought 51.0 Thousand shares of TherapeuticsMD Inc